Sotera Health Co (NASDAQ:SHC) saw an upside of 1.59% to close Friday at $15.38 after adding $0.24 on the day. The 5-day average trading volume is 715,980 shares of the company’s common stock. It has gained $15.58 in the past week and touched a new high 1 time within the past 5 days. An average of 775,395 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 779,334.
SHC’s 1-month performance is -7.18% or -$1.01 on its low of $14.32 reached on 09/08/23. The company’s shares have touched a 52-week low of $5.78 and high of $19.40, with the stock’s rally to the 52-week high happening on 07/19/23. YTD, SHC has achieved 84.63% or $7.05 and has reached a new high 7 times. However, the current price is down -20.72% from the 52-week high price.
Valuation Metrics
SHC stock has a beta of 2.24. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 4.45 while the price-to-book (PB) in the most recent quarter is 10.39.
Sotera Health Co’s quick ratio for the period ended June 29 was 2.50, with the current ratio over the same period at 2.73. As well, the company’s long term debt to equity for the quarter ending June 29 was 5.51, while the total debt to equity was 5.56. In terms of profitability, the gross margin trailing 12 months is 47.65%. The trailing 12-month EBITDA margin is 47.55% while for the period ending June 29, Sotera Health Co’s operating margin was 30.95%. The firm’s gross profit as reported stood at $557.0 million against revenue of $1.0 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -29.39% to $23.51 million, while revenue of $2.84 million was 87.92% off the previous quarter. Analysts expected SHC to announce $0.17 per share in earnings in its latest quarter, but it posted $0.21, representing a 23.50% surprise. EBITDA for the quarter stood at more than $104.9 million. SHC stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 2.66 billion, with total debt at $2.32 billion. Shareholders hold equity totaling $282.62 million.
Let’s look briefly at Sotera Health Co (SHC) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 September was 48.19% to suggest the stock is trending Neutral, with historical volatility in this time period at 20.05%.
The stock’s 5-day moving average is $15.29, reflecting a -1.09% or -$0.17 change from its current price. SHC is currently trading -5.30% above its 20-day SMA, -6.28% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -17.93% and SMA200 by+72.04%.
Stochastic %K and %D was 49.54% and 44.47% and the average true range (ATR) pointed at 0.40. The RSI (14) points at 43.83%, while the 14-day stochastic is at 68.17% with the period’s ATR at 0.43. The stock’s 9-day MACD Oscillator is pointing at 0.05 and 0.17 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Sotera Health Co (NASDAQ: SHC), KeyBanc Capital Markets upgraded it to an Overweight rating. They previously had a Sector weight rating on the stock. Analysts offering their rating for SHC stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate SHC as a “sell,”, while 3 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 2 have offered a “buy” rating.
What is SHC’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $18.00 and a high of $22.00, with their median price target at $20.00. Looking at these predictions, the average price target given by analysts is for Sotera Health Co (SHC) stock is $20.00.
